Current projects, principal investigators, periods, references and research programmes.
Current portfolio
Four active projects connect gastrointestinal disease, antimicrobial resistance, prenatal exposures and early-life biology.
Develops and evaluates biomarkers for intestinal-barrier alterations associated with irritable bowel syndrome, inflammatory bowel disease and coeliac disease, both at diagnosis and after treatment.
csoumar@us.es →Studies genetic, epigenetic and phenotypic mechanisms involved in bacterial adaptation and antimicrobial resistance, combining single-cell technologies with third-generation sequencing to identify mechanisms that may help restore treatment sensitivity.
mtsanchez@us.es →Investigates maternal diet, microbial exposure and other immunomodulatory factors in fetal immune programming through the chemical, metabolic, microbial and immunological characterisation of amniotic fluid.
lmoreno@us.es →Examines how maternal allergen-exclusion diets and infant feeding affect human milk, the intestinal microbiota and mother-infant immunity, with the aim of identifying early mechanisms and biomarkers linked to cow's-milk-protein allergy and coeliac disease.
icomino@us.es →Browse the group's publication record separately from the current project portfolio.